Bhatt Nailesh — SEC insider filings
SEC reporting owner CIK 1806525. 12 insider filings on record with FilingPulse; latest filed 2026-11-09.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2022-04-08 to 2026-11-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 25,000 shares, $5,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: purchase of 25,000 shares @ $0.23 ($5,800) in Sonnet BioTherapeutics Holdings, Inc., filed 2023-05-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sonnet BioTherapeutics Holdings, Inc. (SONN) | Director | 6 | 1 leg · 25,000 sh · $5,800 | — | 5 |
| Hyperliquid Strategies Inc (PURR) | Director | 6 | — | — | 6 |
Insider filings — Bhatt Nailesh
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-09 | 4 | Hyperliquid Strategies Inc (PURR) | Grant/award (A): 17,123 @ $0 | EDGAR |
| 2026-10-15 | 4 | Hyperliquid Strategies Inc (PURR) | Grant/award (A): 2,037 | EDGAR |
| 2026-07-06 | 4 | Hyperliquid Strategies Inc (PURR) | Grant/award (A): 1,588 | EDGAR |
| 2026-04-02 | 4 | Hyperliquid Strategies Inc (PURR) | Grant/award (A): 2,455 @ $0 | EDGAR |
| 2026-02-11 | 4 | Hyperliquid Strategies Inc (PURR) | Grant/award (A): 40,789 @ $0 | EDGAR |
| 2025-12-12 | 4 | Hyperliquid Strategies Inc (PURR) | Other (J): 2,082 | EDGAR |
| 2025-12-03 | 4 | Sonnet BioTherapeutics Holdings, Inc. (SONN) | Disposition to issuer (D): 10,547 | EDGAR |
| 2025-07-15 | 4 | Sonnet BioTherapeutics Holdings, Inc. (SONN) | Grant/award (A): 10,000 | EDGAR |
| 2024-12-05 | 4 | Sonnet BioTherapeutics Holdings, Inc. (SONN) | Grant/award (A): 373 | EDGAR |
| 2023-05-18 | 4 | Sonnet BioTherapeutics Holdings, Inc. (SONN) | Purchase (P): 25,000 @ $0.23 | EDGAR |
| 2022-12-22 | 4 | Sonnet BioTherapeutics Holdings, Inc. (SONN) | Grant/award (A): 3,770 | EDGAR |
| 2022-04-08 | 4 | Sonnet BioTherapeutics Holdings, Inc. (SONN) | Grant/award (A): 14,152 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1806525 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs